We are live on
!
Find out more
IC
Inscription Capital Portfolio holdings
AUM
$951M
1-Year Est. Return
23.82%
This Fund
S&P 500
This Quarter
Est. Return
+5.92%
1 Year Est. Return
+23.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$881M
AUM Growth
+$588M
(+201%)
Cap. Flow
+$565M
Cap. Flow
% of AUM
64.17%
Top 10 Holdings %
Top 10 Hldgs %
39.4%
Holding
403
New
211
Increased
71
Reduced
29
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$50.1M |
| 2 |
Vanguard Morningstar Growth ETF
VUG
|
+$48.9M |
| 3 |
Omega Flex
OFLX
|
+$46.2M |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$44.1M |
| 5 |
Apple
AAPL
|
+$35.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$14.9M |
| 2 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$13.5M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$12.8M |
| 4 |
iShares International Treasury Bond ETF
IGOV
|
+$12.6M |
| 5 |
Vanguard Total Bond Market
BND
|
+$9.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Industrials | 13.72% |
| 3 | Financials | 12.06% |
| 4 | Healthcare | 9.37% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOLX
226
DELISTED
Hologic
HOLX
| $367K | 0.04% |
+5,500
| New | +$368K |
|
227
B&G Foods
BGS
$286M
| $366K | 0.04% |
+11,160
| New | +$344K |
|
228
iShares Russell 1000 ETF
IWB
$49.8B
| $361K | 0.04% |
+1,493
| New | +$352K |
|
229
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $355K | 0.04% |
6,537
-44,910
| -87% | -$2.39M |
|
230
Dell
DELL
$299B
| $353K | 0.04% |
+6,988
| New | +$350K |
|
231
Syndax Pharmaceuticals
SNDX
$1.77B
| $352K | 0.04% |
+20,500
| New | +$375K |
|
232
Lumen
LUMN
$6.26B
| $346K | 0.04% |
+25,490
| New | +$352K |
|
233
Hershey
HSY
$36.1B
| $344K | 0.04% |
1,976
-194
| -9% | -$32.7K |
|
|
UMPQ
234
DELISTED
Umpqua Holdings Corp
UMPQ
| $344K | 0.04% |
+18,625
| New | +$347K |
|
235
Carlyle Group
CG
$17.9B
| $335K | 0.04% |
+7,200
| New | +$306K |
|
236
Crown Castle
CCI
$32.3B
| $334K | 0.04% |
+1,710
| New | +$320K |
|
237
Linde
LIN
$226B
| $334K | 0.04% |
+1,155
| New | +$337K |
|
238
Intuitive Surgical
ISRG
$133B
| $328K | 0.04% |
+1,071
| New | +$300K |
|
239
State Street SPDR S&P Biotech ETF
XBI
$9.99B
| $328K | 0.04% |
+2,422
| New | +$318K |
|
|
PARA
240
DELISTED
Paramount Global Class B
PARA
| $327K | 0.04% |
+7,230
| New | +$299K |
|
241
iShares Russell 1000 Value ETF
IWD
$83.2B
| $326K | 0.04% |
+2,057
| New | +$326K |
|
|
ALXN
242
DELISTED
Alexion Pharmaceuticals
ALXN
| $326K | 0.04% |
+1,772
| New | +$304K |
|
243
Consolidated Edison
ED
$39.9B
| $325K | 0.04% |
4,530
+430
| +10% | +$33K |
|
244
Hercules Capital
HTGC
$3.12B
| $324K | 0.04% |
+18,975
| New | +$325K |
|
245
Sabra Healthcare REIT
SBRA
$5.32B
| $322K | 0.04% |
+17,675
| New | +$315K |
|
246
H&R Block
HRB
$5.82B
| $318K | 0.04% |
+13,540
| New | +$321K |
|
247
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $318K | 0.04% |
+3,842
| New | +$318K |
|
248
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
| $317K | 0.04% |
+3,339
| New | +$314K |
|
249
iShares Core S&P Small-Cap ETF
IJR
$112B
| $313K | 0.04% |
2,766
-20,924
| -88% | -$2.33M |
|
250
FTAI Aviation
FTAI
$23B
| $312K | 0.04% |
+10,902
| New | +$275K |
|
Similar funds
LEA
WAM
CFO
GL
PO
IGGA
DG
LOAMU
Inscription Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Inscription Capital held 403 positions worth $881M, up 201% from $293M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Inscription Capital deployed $565M of net new capital in Q2 2021, opening 211 new positions and adding to 71 existing holdings. Its largest new stake was Vanguard Morningstar Growth ETF: 1,076,070 shares worth $51.4M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 11% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $14.9M trimmed.
- Inscription Capital's largest Q2 2021 buy was Vanguard Morningstar Growth ETF: 1,076,070 shares worth $51.4M.
- Inscription Capital added most to JPMorgan Chase in Q2 2021, an estimated $50.1M increase.
- Inscription Capital's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $14.9M.
- Inscription Capital fully exited Goldman Sachs ActiveBeta US Large Cap Equity ETF in Q2 2021, selling an estimated $13.5M.
- Inscription Capital's ten largest holdings make up 39% of its $881M portfolio in Q2 2021.
- Inscription Capital opened 211 new positions and closed 92 in Q2 2021.
- Inscription Capital's portfolio value rose 201% quarter-over-quarter to $881M.
Based on Inscription Capital's 13F filing for Q2 2021, filed 13 Aug 2021.